Market Closed -
Other stock markets
|
Pre-market 09:07:26 am | |||
41.54 USD | -1.89% | 41.76 | +0.52% |
May. 23 | Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment | MT |
May. 22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Official Publications